lactic acid has been researched along with Acquired Immunodeficiency Syndrome in 12 studies
Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.
Acquired Immunodeficiency Syndrome: An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hyperlactatemia and lactic acidosis (LA) are among the most dangerous and life-threatening side effect that occurs during therapy with some nucleoside reverse transcriptase inhibitors (NRTIs), mainly didanosine (ddI) and stavudine (d4T), also known as d-drugs." | 7.78 | The role of nucleoside reverse transcriptase inhibitors usage in the incidence of hyperlactatemia and lactic acidosis in HIV/AIDS patients. ( Dragovic, G; Jevtovic, D, 2012) |
| " Chronic lactic acidosis (lactate, 10 +/- 1 mmol/L) persisted for more than 5 wk." | 7.68 | Chronic lactic acidosis in a patient with acquired immunodeficiency syndrome and mitochondrial myopathy: biochemical studies. ( Cheema-Dhadli, S; Gopinath, R; Halperin, M; Hutcheon, M, 1992) |
| "Hyperlactatemia and lactic acidosis (LA) are among the most dangerous and life-threatening side effect that occurs during therapy with some nucleoside reverse transcriptase inhibitors (NRTIs), mainly didanosine (ddI) and stavudine (d4T), also known as d-drugs." | 3.78 | The role of nucleoside reverse transcriptase inhibitors usage in the incidence of hyperlactatemia and lactic acidosis in HIV/AIDS patients. ( Dragovic, G; Jevtovic, D, 2012) |
| " It could be proposed that patients having one or more of these risk factors undergo regular monitoring of plasma lactate and renal function to prevent lactic acidosis." | 3.73 | Risk factors for hyperlactataemia in HIV-infected patients, Aquitaine Cohort, 1999--2003. ( Balestre, E; Bernardin, E; Bonnet, F; Dabis, F; Neau, D; Pellegrin, JL, 2005) |
| " Chronic lactic acidosis (lactate, 10 +/- 1 mmol/L) persisted for more than 5 wk." | 3.68 | Chronic lactic acidosis in a patient with acquired immunodeficiency syndrome and mitochondrial myopathy: biochemical studies. ( Cheema-Dhadli, S; Gopinath, R; Halperin, M; Hutcheon, M, 1992) |
| "Particularly, patients with acquired immunodeficiency syndrome (AIDS) with low T CD4 counts develop a chronic disease, with severe and widespread forms." | 1.62 | Evolution of virulence-related phenotypes of Sporothrix brasiliensis isolates from patients with chronic sporotrichosis and acquired immunodeficiency syndrome. ( Almeida, MA; Almeida-Paes, R; Brito-Santos, F; Coelho, RA; Cruz, ILR; de Macedo, PM; do Valle, ACF; Figueiredo-Carvalho, MHG; Freitas, DFS; Gutierrez-Galhardo, MC; Zancopé-Oliveira, RM, 2021) |
| "AIDS-related Kaposi's sarcoma (AIDS-KS), the most prevalent HIV-associated malignancy, is a debilitating, potentially fatal disease." | 1.31 | Sustained angiogenesis enables in vivo transplantation of mucocutaneous derived AIDS-related Kaposi's sarcoma cells in murine hosts. ( Kang, J; Mallery, SR; Ness, GM; Pei, P; Schwendeman, SP; Zhu, G, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 7 (58.33) | 29.6817 |
| 2010's | 1 (8.33) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Geng, ST | 1 |
| Zhang, JB | 1 |
| Wang, YX | 1 |
| Xu, Y | 1 |
| Lu, D | 1 |
| Zhang, Z | 1 |
| Gao, J | 1 |
| Wang, KH | 1 |
| Kuang, YQ | 1 |
| Cruz, ILR | 1 |
| Freitas, DFS | 1 |
| de Macedo, PM | 1 |
| Gutierrez-Galhardo, MC | 1 |
| do Valle, ACF | 1 |
| Almeida, MA | 1 |
| Coelho, RA | 1 |
| Brito-Santos, F | 1 |
| Figueiredo-Carvalho, MHG | 1 |
| Zancopé-Oliveira, RM | 1 |
| Almeida-Paes, R | 1 |
| Dragovic, G | 1 |
| Jevtovic, D | 1 |
| Desai, N | 1 |
| Mathur, M | 1 |
| Weedon, J | 1 |
| Dahm, R | 1 |
| Bonnet, F | 1 |
| Balestre, E | 1 |
| Bernardin, E | 1 |
| Pellegrin, JL | 1 |
| Neau, D | 1 |
| Dabis, F | 1 |
| Lewis, W | 2 |
| Haase, CP | 2 |
| Miller, YK | 1 |
| Ferguson, B | 1 |
| Stuart, T | 1 |
| Ludaway, T | 1 |
| McNaught, J | 1 |
| Russ, R | 1 |
| Steltzer, J | 1 |
| Santoianni, R | 1 |
| Long, R | 1 |
| Fiermonte, G | 1 |
| Palmieri, F | 1 |
| van Griensven, J | 1 |
| Atté, EF | 1 |
| Reid, T | 1 |
| Parker, WB | 1 |
| Shaddix, SC | 1 |
| Vince, R | 1 |
| Bennett, LL | 1 |
| Mallery, SR | 1 |
| Pei, P | 1 |
| Kang, J | 1 |
| Zhu, G | 1 |
| Ness, GM | 1 |
| Schwendeman, SP | 1 |
| Raidel, SM | 1 |
| Russ, RB | 1 |
| Sutliff, RL | 1 |
| Hoit, BD | 1 |
| Samarel, AM | 1 |
| Gopinath, R | 1 |
| Hutcheon, M | 1 |
| Cheema-Dhadli, S | 1 |
| Halperin, M | 1 |
1 trial available for lactic acid and Acquired Immunodeficiency Syndrome
| Article | Year |
|---|---|
Pre-Digested Protein Enteral Nutritional Supplementation Enhances Recovery of CD4
Topics: Acquired Immunodeficiency Syndrome; Adult; Amine Oxidase (Copper-Containing); Anti-HIV Agents; Bacte | 2021 |
11 other studies available for lactic acid and Acquired Immunodeficiency Syndrome
| Article | Year |
|---|---|
Evolution of virulence-related phenotypes of Sporothrix brasiliensis isolates from patients with chronic sporotrichosis and acquired immunodeficiency syndrome.
Topics: Acetylglucosamine; Acquired Immunodeficiency Syndrome; Adult; Animals; Antifungal Agents; Biological | 2021 |
The role of nucleoside reverse transcriptase inhibitors usage in the incidence of hyperlactatemia and lactic acidosis in HIV/AIDS patients.
Topics: Acidosis, Lactic; Acquired Immunodeficiency Syndrome; Adult; CD4 Lymphocyte Count; Didanosine; Drug | 2012 |
Lactate levels in children with HIV/AIDS on highly active antiretroviral therapy.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Anti-HIV Agents; Antiretroviral Therapy, Highly Acti | 2003 |
Dying to see.
Topics: Acquired Immunodeficiency Syndrome; Aged; Aging; Alzheimer Disease; Animals; Apoptosis; Cataract; Ey | 2004 |
Risk factors for hyperlactataemia in HIV-infected patients, Aquitaine Cohort, 1999--2003.
Topics: Acidosis, Lactic; Acquired Immunodeficiency Syndrome; Adult; Age Factors; Anti-HIV Agents; CD4 Antig | 2005 |
Transgenic expression of the deoxynucleotide carrier causes mitochondrial damage that is enhanced by NRTIs for AIDS.
Topics: Acquired Immunodeficiency Syndrome; Animals; Antiretroviral Therapy, Highly Active; Electrocardiogra | 2005 |
Symptomatic hyperlactatemia: lessons learned using a point-of-care device in a health care center- and nurse-based antiretroviral program in Rwanda.
Topics: Acidosis, Lactic; Acquired Immunodeficiency Syndrome; Ambulatory Care Facilities; Anti-HIV Agents; A | 2008 |
Lack of mitochondrial toxicity in CEM cells treated with carbovir.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Cell Line; Dideoxynucleosides; DNA, Mitochondri | 1997 |
Sustained angiogenesis enables in vivo transplantation of mucocutaneous derived AIDS-related Kaposi's sarcoma cells in murine hosts.
Topics: Acquired Immunodeficiency Syndrome; Animals; Cattle; Delayed-Action Preparations; Disease Models, An | 2000 |
Combined antiretroviral therapy causes cardiomyopathy and elevates plasma lactate in transgenic AIDS mice.
Topics: Acquired Immunodeficiency Syndrome; Animals; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; | 2001 |
Chronic lactic acidosis in a patient with acquired immunodeficiency syndrome and mitochondrial myopathy: biochemical studies.
Topics: Acidosis, Lactic; Acquired Immunodeficiency Syndrome; Adult; Exercise; Humans; Kidney; Lactates; Lac | 1992 |